Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Study reveals new aptamer targeting tool can detect early signs of motor neurone disease

The fatal, progressive neurological condition currently affects around 5,000 people in the UK

April 4, 2024 aptamer, motor neurone disease, neurological conditions, News, University of Aberdeen, University of Edinburgh

Study reveals new liquid biopsy test could benefit thousands of lung cancer patients

The third most common and serious form of cancer affects over 43,000 people every year in the UK

April 3, 2024 circulating tumour DNA, Guardant Health, lung cancer, Marsden360, News, NHS England, Oncology, The Royal Marsden

Researchers suggest form of Alzheimer’s is transmissible via bone marrow transplants

The progressive neurodegenerative disease is estimated to affect 24 million people globally

April 3, 2024 Alzheimer's disease, amyloid, amyloid precursor protein, bone marrow transplants, Dementia, neurodegenerative diseases, News, University of British Columbia

Collaborators form national NHS patient database registry for Lynch syndrome patients

The genetic condition affects one in 279 people in England and significantly increases cancer risk

April 2, 2024 Cancer, English National Lynch Syndrome Registry, Institute of Cancer Research, Lynch syndrome, National Disease Registration Service, News, NHS Genomic Medicine Service Alliances, NHS Regional Clinical Genetics Services

Researchers reveal people with Parkinson’s more likely to experience delirium in hospital

Two out of three people with the neurodegenerative condition experienced delirium in hospital

April 2, 2024 delirium, neurogenerative conditions, Newcastle University, News, Parkinson's disease, Parkinson’s UK

Strand Therapeutics develops new class of mRNA molecules for cancer

The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases

March 28, 2024 Cancer, immunotherapies, mRNA molecules, News, Oncology, Strand Therapeutics

University of Liverpool to lead £125m research facility supported by UKRI investment

Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m

March 28, 2024 News, personalised medicine, Relativistic Ultrafast Electron Diffraction and Imaging, Rosalind Franklin Institute, Science and Technology Facilities Council, UK Research and Innovation, University of Liverpool

PMLiVE’s T40 – open for submissions!

Healthcare agencies can submit their entries free of charge with a deadline of 30 April

March 28, 2024 creative healthcare agencies, News, T40 2024, UK healthcare sector

LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy

The progressive and incurable brain disorder currently affects approximately 100 patients worldwide

March 27, 2024 DefINe, Ferriprox, LifeArc, Lipomed, neuroferritinopathy, News, ultra-rare genetic diseases, University of Cambridge

PhaSER Biomedical and the Sanders TDI partner for clinical drug discovery research

PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets

March 27, 2024 8HUM, drug discovery, Memorial Sloan Ketterine Cancer Center, News, PhaSER Biomedical, Rockefeller University, Sanders Tri-Institutional Therapeutic Discovery Institute, Weill Cornell Medicine

Posts navigation

Posts pagination

« Previous 1 … 53 54 55 … 67 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy